Cargando…
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Parkinson’s disease (PD) is a slow insidious neurological disorder characterized by a loss of dopaminergic neurons in the midbrain. Although several recent preclinical advances have proposed to treat PD, there is hardly any clinically proved new therapeutic for its cure. Increasing evidence suggests...
Autores principales: | More, Sandeep Vasant, Choi, Dong-Kug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404240/ https://www.ncbi.nlm.nih.gov/pubmed/25888232 http://dx.doi.org/10.1186/s13024-015-0012-0 |
Ejemplares similares
-
Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012) -
Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017) -
Emerging preclinical pharmacological targets for Parkinson's disease
por: More, Sandeep Vasant, et al.
Publicado: (2016) -
Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013) -
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)